NMN vs NR: Which NAD+ Booster Is Actually Better?
Ask a longevity community which NAD+ supplement to take and you'll start a fight. One camp swears by NMN — made famous by Harvard scientist David Sinclair. The other swears by NR, sold by major brands and backed by more clinical trials. Here's what the science actually says.
📋 Simple Summary
NMN and NR are two molecules your body can turn into NAD+, which is like fuel for your cells. As you age, your NAD+ levels drop, so people take NMN or NR to top them back up.
Both of them work. Both raise NAD+ in human studies. So which one is better?
The honest answer is: we don't know for sure, because no big human study has tested them head-to-head. But right now, NR has a real practical edge — it has been studied in more human trials, and it is still legal to sell in the US. NMN was actually banned as a supplement in the US in 2022. So for most people, NR is the safer, better-proven choice today.
The detailed breakdown continues below for those who want the full science.
🥈 Evidence Tier: Silver (for both)
Both have human trials showing they raise NAD+. NR has more trials overall. Neither has a human lifespan study. This is a comparison between two Silver-tier molecules, not a Gold-tier winner.
The short answer
There's no proven winner — but NR has the practical edge right now.
Both molecules do the same core job: raise NAD+. The difference comes down to three things: the biology (small vs. large molecule), the amount of human evidence, and the law.
What they actually are
Both NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are NAD+ precursors — building blocks your body converts into NAD+.
- NR is smaller. It enters cells directly and is converted to NAD+ inside. It's a single step away.
- NMN is one step larger. It must either be converted to NR first, or be carried into cells by a specific transporter (called Slc12a8).
In the body these two pathways overlap heavily — both ultimately end up boosting NAD+. That's why neither has a clear biological knockout win. Source: Covarrubias et al., Nature Reviews Molecular Cell Biology, 2021. PMID: 33353981
The evidence gap: who has more human data?
This is where NR pulls ahead. NR has been through more human clinical trials than NMN. The strongest NR result:
- NADPARK study (2022) — 30 newly-diagnosed Parkinson's patients took 1,000 mg of NR daily for 30 days. NR was safe, and it raised NAD+ levels in the brain itself (measured by magnetic resonance spectroscopy), with signs of mild clinical improvement. That's a stronger result than most NMN trials have shown. PMID: 35235774
NMN's best human result is the 2023 trial of 80 adults showing raised NAD+ and a better six-minute walk — solid, but it's one trial, and NMN has fewer human studies overall. A 2023 review comparing the two concluded both raise NAD+, with no clear winner. PMID: 37273100
The law: the tiebreaker most people miss
Here's the part that matters more than the biology: NMN is no longer legal to sell as a supplement in the US.
In November 2022, the FDA ruled NMN cannot be marketed as a dietary supplement because it was first authorized for investigation as a drug. Products labeled "NMN" still circulate online, but they're unregulated — no one verifies purity, dose, or even that they contain real NMN.
NR, by contrast, remains legal and is sold by major, reputable supplement brands. For a supplement you're going to take daily, "can I actually trust what's in the bottle" is a real factor — and NR wins it hands down.
Our Take
Both raise NAD+. Neither is proven to extend human lifespan. So the decision comes down to evidence and trust: NR has more human trials and is legally sold in the US; NMN is banned and its online sellers are unregulated. Until a head-to-head human trial says otherwise, NR is the more sensible default. For the full biology of NAD+ and NMN specifically, read our NMN deep dive and our "Does NMN actually work?" breakdown.
❓ Common Questions About NMN vs NR
Which is better, NMN or NR?
There is no head-to-head human trial proving one is better. Both raise NAD+ levels in humans. On paper, NR currently has the edge: it has more human clinical trials behind it and it is still legal to sell as a supplement in the US, while NMN was removed from the US market in 2022.
What is the actual difference between NMN and NR?
Both are building blocks for NAD+. NR is a smaller molecule that enters cells directly and is converted to NAD+. NMN is one step larger and must either be converted to NR first or carried into cells by a specific transporter. In the body, the two are closely connected and both end up boosting NAD+.
Does NR actually work in humans?
Yes, NR reliably raises NAD+ in human trials. A 2022 Parkinson's disease trial (NADPARK) found 1,000 mg daily raised brain NAD+ levels in patients, with no safety problems. NR has been studied in more human trials than NMN overall.
Is NMN still legal to buy?
In the US, no. In November 2022 the FDA ruled NMN cannot be sold as a dietary supplement because it was first investigated as a drug. Products labeled NMN still circulate online but are unregulated and unverified. NR remains legal and is sold by major supplement brands.
What is the right dose for NR?
Human trials have used 250 mg to 1,000 mg of NR per day. The Parkinson's trial used 1,000 mg daily safely for 30 days. There is no proven longevity dose for either NR or NMN.
The Bottom Line
NMN vs NR: no proven winner, but NR is the better default today. Both raise NAD+. NR has more human trials and is legally sold in the US; NMN is banned and its sellers are unregulated. Evidence tier: 🥈 Silver for both. Who NR is for: anyone wanting a NAD+ boost with the most human data and legal backing behind it.
⚠️ Medical Disclaimer: This article is for information only and is not medical advice. NMN cannot legally be sold as a supplement in the US. Talk to your doctor before starting any supplement, especially if you take medication or have a health condition.
Sources
- Brakedal B, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 2022. PMID: 35235774
- Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. GeroScience. 2023. PMID: 36482258
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. PMID: 33888596
- Karim M, et al. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health. Current Nutrition Reports. 2023. PMID: 37273100
- Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021. PMID: 33353981
- Nadeeshani H, et al. Nicotinamide mononucleotide (NMN) as an anti-aging health product — Promises and safety concerns. Journal of Advanced Research. 2022. PMID: 35499054